Lotte Westerink

3PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 30, 2024
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade.

Lotte Westerink, Sharon Wolters, Guiling Zhou

|Aug 04, 2022
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD).

Lotte Westerink, Jelmer Lennart Jens Nicolai, Maarten Jacobus Postma

|Apr 25, 2020
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations.

Lotte Westerink, Jelmer L J Nicolai, Carl Samuelsen

Pageof 1